Hastings, Nataly https://orcid.org/0000-0002-5376-339X
Rahman, Saifur
Stempor, Przemyslaw Aleksander
Wayland, Matthew T.
Kuan, Wei-Li
Kotter, Mark R. N.
Funding for this research was provided by:
Addenbrooke’s Charitable Trust (900218)
Ferblanc
Rosetrees Trust (Seedcorn2020\100084)
Wellcome Trust (Developing Concept Fund)
Medical Research Council (Confidence in Concept, MRC, MR/S005528/1)
Multiple Sclerosis Society (100)
National Institute for Health and Care Research (Clinician Scientist Award)
Article History
Received: 10 December 2024
Accepted: 12 March 2025
First Online: 25 March 2025
Declarations
:
: N.H. is a director; N.H., S.R., and P.A.S. are shareholders in “Cellestial Health Ltd.”, a spin-off company from the University of Cambridge that explores astrocytic networks as therapeutic targets in Parkinson’s disease and other conditions of the brain. The spin-off was created as a result of the academic work, including the results presented herewith. The other authors have no competing interests to declare.